Delivery Order SPE2DB20D3103-SPE2DB23FN7L4

Award Date 6/20/23
Potential Completion Date 6/21/23
Potential Value $1.1K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Depakote DR 125 mg sprinkle capsules to the Defense Logistics Agency (DLA). The contract, valued at $5,963.30, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of December 5, 2023. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is for the delivery of Depakote DR 125 mg sprinkle capsules to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,132.29 and was awarded on May 26, 2022, with a completion date of May 27, 2022. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Depakote DR 125 mg sprinkle capsules. The Delivery Order, valued at $1,350.72, is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, worth up to $999,999,999.00 through December 2025. This IDC serves as the primary vehicle for Amerisourcebergen to supply a wide range of...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $1,383.36 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and subsidiary of Cencora, Inc. This contract is for the delivery of 4,563,172,594 units of the prescription medication Depakote DR 250 mg tablets. The contract has a completion date of December 26, 2023 and uses a Firm Fixed Price pricing type. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a...
This federal contract award, valued at $1,067.92, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp. for the delivery of 4,565,232 units of Depakote DR 125 mg Sprinkle capsules. The contract has a completion date of July 24, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded multiple Indefinite Delivery Contracts (IDCs) by the DLA Troop Support Medical and the Department of Justice Federal Bureau of Investigation to...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $1,446.60 and is a Firm Fixed Price Delivery Order for the supply of Depakote DR 125 mg Sprinkle Capsules. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen also holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of pharmaceutical products, including Depakote DR 250 mg tablets, to the Defense Logistics Agency (DLA). The $1,154.25 delivery order is a firm fixed-price contract with a completion date of June 5, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as the primary vehicle for the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,164.33 firm fixed-price delivery order is for the supply of Depakote DR 125 mg sprinkle capsules to support military treatment facilities and federal healthcare programs. The award is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite...
This federal contract award, with ID SPE2DB20D1004|SPE2DB24FE8J4, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4562729774 DEPAKOTE DR 125 MG SPRINKLE CP 100S, with a ceiling value of $1,413.36 and a completion date of November 7, 2023. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant...
This is a federal contract award valued at $1,170.88 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, for the delivery of divalproex delayed-release capsules. The contract is a delivery order, with a firm fixed price pricing type and an ultimate completion date of November 26, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB23FN7L4
    Delivery Order

This federal contract award is for the delivery of Depakote DR 125 mg sprinkle capsules to the Defense Logistics Agency (DLA) by the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Firm Fixed Price Delivery Order valued at $1,106.58 with a performance period through June 2023. The contract was awarded on June 20, 2023 and does not have a set-aside designation, indicating open competition.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support Department of Defense and Veterans Affairs healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued up to $750,000, for similar medical commodities.

Generated 2/27/25, 11:24 AM